Quality of Life Model for Older Patients With AML
Running, not enrolling
Conditions studied: AML, Adult, Acute Myeloid Leukemia
In brief
The purpose of this study is to describe the differences in quality of life (QOL) among newly diagnosed patients diagnosed with acute myeloid leukemia (AML) to help design a patient decision-making QOL model for aligning patients' choice of treatment with what matters the most to them.
Key facts
- Study ID
- NCT04380441
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
- People needed
- 206
- Starts
- 2020-07-08
- Expected to finish
- 2027-07-01
- Last updated by the study team
- 2026-05-18
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 60 years of age or older
- Newly diagnosed with pathology-confirmed diagnosis of Acute Myeloid Leukemia
- Within 7 days of starting a new treatment
- Must be able to read and speak English at the 8th grade level
You may not qualify if…
- Under 60 years of age
- Other malignancy, dementia, traumatic brain injury or individuals with central nervous system involvement of their leukemia
Where it is running
- Moffitt Cancer Center — Tampa, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.